Skip to main content
SpringerLink
Log in
Book cover

Therapiekonzepte Onkologie pp 1186–1201Cite as

Chorionkarzinom und destruierende Blasenmole (gestationsbedingte Trophoblasterkrankungen)

  • Chapter

  • 68 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Azab M, Droz JP, Theodore C et al. (1989) Cisplatin, Vinblastine, and Bleomycin combination in the Treatment of Resistant High-Risk Gestational Trophoblastic Tumors. Cancer 64:1829–1832

    Article  PubMed  CAS  Google Scholar 

  2. Bagshawe KD, Dent J, Newlands ES, Begent RHJ, Rustin GJS (1989) The Role of Low-Dose Methotrexate and Folinic Acid in Gestational Trophoblastic Tumours (GTT). Br J Obstet Gynecol 96:795–802

    Article  CAS  Google Scholar 

  3. Bagshawe KD (1992) Trophoblastic tumors: Diagnostic Methods, Epidemiology, Clinical Features and Management. In: Coppleson M (ed): Gynecologic Oncology. Churchill Livingstone, Edinburgh London Melbourne New York Tokyo, pp 1027–1043

    Google Scholar 

  4. Bower M, Newlands ES, Holden L, Short D, Rustin GJS, Begent RHJ, Bagshawe KD (1997) EMA/CO for high-risk gestational trophoblastic tumors: Results from a cohort of 272 patients. J Clin Oncol 15:2636–2643

    PubMed  CAS  Google Scholar 

  5. Erazo A, Cervates G, Torrecilas L, Robles J (1994) Management of high risk trophoblastic neoplasms: Experience with Etoposide, Methotrexate, A Actinomycin, Cyclophosphamide, Vincristine (EMA-CO). Proc Am Soc Clin Oncol 13:265 (A 844)

    Google Scholar 

  6. Fasoli M, Ratti E, Franceschi S et al. (1982) Management of Gestational Trophoblastic Disease: Results of a Cooperative Study. Obstet Gynecol 60:205–209

    PubMed  CAS  Google Scholar 

  7. Hammond CB, Borchert LG, Tyrey L et al. (1973) Treatment of Metastatic Trophoblastic Disease: Good and Poor Prognosis. Am J Obstet Gynecol 115(4):451–457

    PubMed  CAS  Google Scholar 

  8. Kashimura Y, Kashimura M, Sugimori H et al. (1986) Prophylactic Chemotherapy for Hydatidiform Mole. Cancer 58:624–629

    Article  PubMed  CAS  Google Scholar 

  9. Loehrer PJ, Einhorn LH, Williams SD (1986) VP-16 Plus Ifosfamide Plus Cisplatin as Salvage Therapy in Refractory Germ Cell Cancer. J Clin Oncol 4:528–536

    PubMed  Google Scholar 

  10. Newlands ES, Bagshawe KD, Begent RHJ et al. (1986) Development in Chemotherapy for Medium- and High-Risk Patients with Gestational Trophoblastic Tumours (1979–1984) Br J Obstet Gynecol 93:63–69

    Article  CAS  Google Scholar 

  11. Petrilli ES, Morrow CP (1980) Actinomycin D Toxicity in the Treatment of Trophoblastic Disease. Gynecol Oncol 9:18–22

    Article  PubMed  CAS  Google Scholar 

  12. Schmidt-Matthiesen H, Bastert G (1993) Gynäkologische Onkologie, Schattauer Verl Stuttgart New York, pp 89–93

    Google Scholar 

  13. Smith EB, Weed JC, Tyrey L, Hammond CB (1982) Treatment of Nonmetastatic Gestational Trophoblastic Disease: Results of Methotrexate Alone versus Methotrexate-Folinic Acid. Am J Obstet Gynecol 144:88–92

    PubMed  CAS  Google Scholar 

  14. Soper JT, Clarke-Pearson D, Hammond CB (1988) Metastatic Gestational Trophoblastic Disease: Prognostic factors in Previusly Untreated patients. Obstet Gynecol 71(3): 338–343

    PubMed  CAS  Google Scholar 

  15. Soper JT, Hammond CB, Lewis JL Jr (1992) Gestational Trophoblastic Disease. In. Hoskins WJ, Perez CA, Young RC (eds): Principles and Practice of Gynecologic Oncology. JB Lippincott Co, Philadelphia, pp 795–825

    Google Scholar 

  16. Soper JT, Evans AC, Clarke-Person DL, Berchuck A, Rodriguez G, Hammond CB (1994) Alternating weekly chemotherapy with Etoposide-Methotrexate-Dactinomycin/Cyclophosphamide-Vincristine for high-risk gestational trophoblastic disease. Obstet Gynecol 83(1): 113–117

    PubMed  CAS  Google Scholar 

  17. Theodore C, Azab M, Droz JP et al. (1989) Treatment of High-Risk Gestational Trophoblastic Disease With Chemotherapy Combinations Containing Cisplatin and Etoposide. Cancer 64:1824–1828

    Article  PubMed  CAS  Google Scholar 

  18. Wong LC, Choo YC, Ma HK (1985) Methotrexate with Citrovorum Factor Rescue in Gestational Trophoblastic Disease. Am J Obstet Gynecol 152–162

    Google Scholar 

Download references

Authors
  1. G. Bastert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. D. Costa
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Innere Klinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen, Hufelandstraße 55, 45122, Essen, Deutschland

    Siegfried Seeber  & Jochen Schütte  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bastert, G., Costa, S.D. (1998). Chorionkarzinom und destruierende Blasenmole (gestationsbedingte Trophoblasterkrankungen). In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10493-4_51

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10493-4_51

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-63821-6

  • Online ISBN: 978-3-662-10493-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation